# Comparison of IONM Between Remimazolam and Propofol

> **NCT04968054** · NA · COMPLETED · sponsor: **Gangnam Severance Hospital** · enrollment: 66 (actual)

## Conditions studied

- Ossification Posterior Longitudinal Ligament
- Cervical Spondylotic Myelopathy

## Interventions

- **DRUG:** Arm I (Propofol)
- **DRUG:** Arm II (Remimazolam)

## Key facts

- **NCT ID:** NCT04968054
- **Lead sponsor:** Gangnam Severance Hospital
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2021-07-20
- **Primary completion:** 2023-05-02
- **Final completion:** 2023-05-02
- **Target enrollment:** 66 (ACTUAL)
- **Last updated:** 2023-10-18


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04968054

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04968054, "Comparison of IONM Between Remimazolam and Propofol". Retrieved via AI Analytics 2026-07-19 from https://api.ai-analytics.org/clinical/NCT04968054. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*